Skip to main content
. 2020 Dec 16;47(2):633–642. doi: 10.3892/ijmm.2020.4820

Figure 7.

Figure 7

Potential mechanism by which melatonin may affect RANKL-induced osteoclastogenesis. Melatonin may first decrease miR-882 expression, then augment Rev-erbα expression and decrease cathepsin K expression, ultimately inhibiting osteoclastogenesis. RANKL, receptor activator of nuclear factor-κB ligand; miR, microRNA; Rev-erbα/NR1D1, nuclear receptor subfamily 1 group D member 1.